Welcome to our dedicated page for Marpai news (Ticker: MRAI), a resource for investors and traders seeking the latest updates and insights on Marpai stock.
Marpai, Inc. reports recurring developments in healthcare technology, third-party administration and pharmacy benefit management services for employers that directly fund employee health benefits. The company operates subsidiaries that provide TPA, PBM and value-oriented health plan services, including the MarpaiRx pharmacy benefit platform and the Marpai Saves initiative.
News about MRAI commonly covers MarpaiRx client wins, marketing collaborations, network access arrangements with providers such as Aetna and Cigna, financial results, operating efficiency initiatives and leadership changes tied to its health benefits administration business.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Marpai, Inc. (Nasdaq: MRAI) has successfully closed a public offering of 7,400,000 shares at a price of $1.00 per share, generating gross proceeds of $7,400,000. The funds will be allocated towards debt repayment related to the acquisition of Maestro Health, amounting to at least 35% of the raised capital, while the remainder will support general corporate purposes. ThinkEquity served as the sole book-running manager for this offering, conducted under an effective shelf registration with the SEC. Marpai focuses on using AI to enhance health plan services for employers engaging in self-funding, tapping into the large $22 billion TPA sector with a target market exceeding $1 trillion in annual claims.